Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daily vs Twice Daily Tamsulosin for Ureteral Stent Symptoms
NCT03799120Phase 4Unknown
- Sponsor
- Gundersen Medical Foundation
- Start
- Feb 2019
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in ureteral stent syndrome (SRS) comparing tamsulosin QD + Placebo with tamsulosin BID (2 arms). Primary endpoint: Ureteric Stent Symptoms Questionnaire at 1 week. Status: unknown.
02
Drugs
tamsulosin
03
Conditions
ureteral stent syndrome (SRS)
Beyond the preview
Go deeper on NCT03799120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03799120.